Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016883246> ?p ?o ?g. }
- W2016883246 endingPage "307" @default.
- W2016883246 startingPage "297" @default.
- W2016883246 abstract "Most of the genes for hereditary tumor syndromes cloned thus far have subsequently been shown to be mutated not only in the germlines and tumors from patients with the relatively rare inherited disease, but also in the much more common sporadic tumor counterparts in the general population. Thus, the isolation and functional characterization of genes associated with hereditary tumor syndromes have emerged as a major strategy to gain insights into some of the most fundamental mechanisms of tumorigenesis. The search for the genes causing two hereditary tumor syndromes of the nervous system, neurofibromatosis type 2 (NF2) and von Hippel-Lindau disease (VHL), has recently culminated in the cloning of both disease genes. This represents another successful application of the so-called positional cloning approach, i.e., the isolation of a hereditary disease gene with unknown function, based on the determination of its chromosomal location in the human genome. The gene for NF2, a syndrome typically associated with vestibular schwannomas and meningiomas, is homologous with a family of genes whose members appear to play an important role in bridging the cell membrane with the intracellular cytoskeleton, including moesin, ezrin, radixin, and protein 4.1. Recent mutation analyses have revealed that the NF2 tumor suppressor gene is frequently mutated not only in vestibular schwannomas and meningiomas from NF2 patients, but also in their sporadic counterparts, which represent approximately one-third of all human brain tumors. Furthermore, malignant human tumors seemingly unrelated to the NF2 syndrome, such as neural crest-derived malignant melanomas, as well as malignant mesotheliomas (a pleural mesoderm-derived tumor), have also been found to be frequently mutated or deleted in the NF2 locus, suggesting a broader role for the NF2 gene in the initiation and progression of human neoplasms. VHL is a rare tumor syndrome characterized by certain types of nervous system tumors (cerebellar and spinal hemangioblastomas as well as retinal angiomas), in conjunction with bilateral renal cell carcinomas and pheochromocytomas. Similar to NF2, recent genetic mutation studies have revealed that the VHL tumor suppressor gene is not only mutated in the hereditary tumors from VHL patients, but also in their sporadic counterparts. Importantly, the VHL gene represents the most frequently mutated cancer-related gene thus far identified in sporadic renal cell carcinoma. In contrast to most other hereditary cancer syndromes, however, VHL mutations are surprisingly specific for tumors typically associated with the VHL syndrome, and have not been detected in any other tumor type unrelated to VHL. The cloning and initial genetic characterization of the NF2 and VHL genes have now provided a rational basis for subsequent functional studies on the elucidation of the normal and tumor-associated cellular signaling pathways of these tumor suppressor genes." @default.
- W2016883246 created "2016-06-24" @default.
- W2016883246 creator A5024586439 @default.
- W2016883246 creator A5032398736 @default.
- W2016883246 creator A5047769764 @default.
- W2016883246 date "1995-11-01" @default.
- W2016883246 modified "2023-09-25" @default.
- W2016883246 title "Neurofibromatosis type 2 and von Hippel‐Lindau disease: From gene cloning to function" @default.
- W2016883246 cites W1565405983 @default.
- W2016883246 cites W1568681949 @default.
- W2016883246 cites W1896894748 @default.
- W2016883246 cites W1965188891 @default.
- W2016883246 cites W1970901330 @default.
- W2016883246 cites W1972651910 @default.
- W2016883246 cites W1973854912 @default.
- W2016883246 cites W1990430938 @default.
- W2016883246 cites W1990880437 @default.
- W2016883246 cites W1995263093 @default.
- W2016883246 cites W1996275548 @default.
- W2016883246 cites W1996875576 @default.
- W2016883246 cites W2005149045 @default.
- W2016883246 cites W2006506188 @default.
- W2016883246 cites W2010160635 @default.
- W2016883246 cites W2010965145 @default.
- W2016883246 cites W2019185977 @default.
- W2016883246 cites W2025150927 @default.
- W2016883246 cites W2028400858 @default.
- W2016883246 cites W2028803434 @default.
- W2016883246 cites W2029136337 @default.
- W2016883246 cites W2029976610 @default.
- W2016883246 cites W2032800886 @default.
- W2016883246 cites W2035734782 @default.
- W2016883246 cites W2043787859 @default.
- W2016883246 cites W2058586797 @default.
- W2016883246 cites W2068555261 @default.
- W2016883246 cites W2070452292 @default.
- W2016883246 cites W2070491420 @default.
- W2016883246 cites W2071456395 @default.
- W2016883246 cites W2071639722 @default.
- W2016883246 cites W2077798900 @default.
- W2016883246 cites W2077858999 @default.
- W2016883246 cites W2090040363 @default.
- W2016883246 cites W2090336665 @default.
- W2016883246 cites W2090369455 @default.
- W2016883246 cites W2090648810 @default.
- W2016883246 cites W2092369394 @default.
- W2016883246 cites W2100868490 @default.
- W2016883246 cites W2101628607 @default.
- W2016883246 cites W2104254247 @default.
- W2016883246 cites W2107151898 @default.
- W2016883246 cites W2118167935 @default.
- W2016883246 cites W2123724520 @default.
- W2016883246 cites W2139810493 @default.
- W2016883246 cites W2141143492 @default.
- W2016883246 cites W2144312285 @default.
- W2016883246 cites W2152649399 @default.
- W2016883246 cites W2154318942 @default.
- W2016883246 cites W2154459309 @default.
- W2016883246 cites W2158957516 @default.
- W2016883246 cites W2161024497 @default.
- W2016883246 cites W2161807488 @default.
- W2016883246 cites W2340144735 @default.
- W2016883246 cites W2415494887 @default.
- W2016883246 cites W4251682350 @default.
- W2016883246 cites W74923221 @default.
- W2016883246 doi "https://doi.org/10.1002/glia.440150310" @default.
- W2016883246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8586465" @default.
- W2016883246 hasPublicationYear "1995" @default.
- W2016883246 type Work @default.
- W2016883246 sameAs 2016883246 @default.
- W2016883246 citedByCount "16" @default.
- W2016883246 countsByYear W20168832462014 @default.
- W2016883246 countsByYear W20168832462015 @default.
- W2016883246 countsByYear W20168832462016 @default.
- W2016883246 countsByYear W20168832462019 @default.
- W2016883246 countsByYear W20168832462022 @default.
- W2016883246 crossrefType "journal-article" @default.
- W2016883246 hasAuthorship W2016883246A5024586439 @default.
- W2016883246 hasAuthorship W2016883246A5032398736 @default.
- W2016883246 hasAuthorship W2016883246A5047769764 @default.
- W2016883246 hasConcept C104317684 @default.
- W2016883246 hasConcept C127716648 @default.
- W2016883246 hasConcept C142669718 @default.
- W2016883246 hasConcept C142724271 @default.
- W2016883246 hasConcept C1491633281 @default.
- W2016883246 hasConcept C196509110 @default.
- W2016883246 hasConcept C2778264664 @default.
- W2016883246 hasConcept C2778679214 @default.
- W2016883246 hasConcept C2778886567 @default.
- W2016883246 hasConcept C2778984943 @default.
- W2016883246 hasConcept C2779134260 @default.
- W2016883246 hasConcept C2780246058 @default.
- W2016883246 hasConcept C3020804800 @default.
- W2016883246 hasConcept C502942594 @default.
- W2016883246 hasConcept C54355233 @default.
- W2016883246 hasConcept C555283112 @default.
- W2016883246 hasConcept C71924100 @default.
- W2016883246 hasConcept C86803240 @default.